Drug-cosmetic boundary: Claims about treating skin conditions, healing damage, or providing therapeutic benefits may trigger drug classification requirements
Research Context and Product Categorisation Compounds such as 5-Amino-1MQ sit within a complex landscape that includes dietary supplements, investigational compounds, and prescription-only therapies
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
Polar Peptides supplies high-purity research products, peptide blends, laboratory-use materials, and advanced analytical compounds manufactured with quality, consistency, and secure packaging in mind
In other research, obese mice on a high-fat diet given 5-Amino-1MQ had roughly a 5% reduction in body weight in just 11 days and improved insulin sensitivity
We will look at how to manage these cases, focusing on intensive treatment and addressing neurological issues
